Hunan Er Kang Pharmaceutical (300267) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.034x

Based on the latest financial reports, Hunan Er Kang Pharmaceutical (300267) has a cash flow conversion efficiency ratio of 0.034x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥174.55 Million ≈ $25.54 Million USD) by net assets (CN¥5.09 Billion ≈ $745.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hunan Er Kang Pharmaceutical net asset quality index to measure how much of total assets are equity-financed.

Hunan Er Kang Pharmaceutical - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Hunan Er Kang Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300267 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Hunan Er Kang Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Er Kang Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ningxia Building Materials Group Co Ltd SHG:600449	0.044x
Jiangsu Longda Superalloy Co. Ltd. A SHG:688231	N/A
Pexa Group Ltd AU:PXA	0.060x
Usinas Siderúrgicas de Minas Gerais S.A SA:USIM3	0.016x
BKS Bank AG VI:BKS	-0.098x
Yutong Optical SHE:300790	0.026x
Controladora Vuela Compañía de Aviación S.A.B. de C.V MX:VOLARA	1.213x
Dogus Otomotiv Servis ve Ticaret AS IS:DOAS	-0.041x

Annual Cash Flow Conversion Efficiency for Hunan Er Kang Pharmaceutical (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Er Kang Pharmaceutical from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 300267 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.40 Billion ≈ $644.18 Million	CN¥166.69 Million ≈ $24.39 Million	0.038x	+22.71%
2023-12-31	CN¥4.81 Billion ≈ $703.86 Million	CN¥148.42 Million ≈ $21.72 Million	0.031x	-44.54%
2022-12-31	CN¥5.05 Billion ≈ $739.13 Million	CN¥281.02 Million ≈ $41.12 Million	0.056x	+192.56%
2021-12-31	CN¥4.87 Billion ≈ $713.18 Million	CN¥92.68 Million ≈ $13.56 Million	0.019x	-38.29%
2020-12-31	CN¥5.79 Billion ≈ $847.78 Million	CN¥178.53 Million ≈ $26.12 Million	0.031x	-59.96%
2019-12-31	CN¥5.79 Billion ≈ $847.71 Million	CN¥445.82 Million ≈ $65.24 Million	0.077x	+250.28%
2018-12-31	CN¥5.64 Billion ≈ $825.21 Million	CN¥123.89 Million ≈ $18.13 Million	0.022x	-82.75%
2017-12-31	CN¥5.41 Billion ≈ $791.90 Million	CN¥689.11 Million ≈ $100.84 Million	0.127x	+37.27%
2016-12-31	CN¥5.24 Billion ≈ $767.41 Million	CN¥486.50 Million ≈ $71.19 Million	0.093x	-23.90%
2015-12-31	CN¥4.26 Billion ≈ $622.97 Million	CN¥518.96 Million ≈ $75.94 Million	0.122x	+16.62%
2014-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥175.38 Million ≈ $25.66 Million	0.105x	-19.97%
2013-12-31	CN¥1.33 Billion ≈ $195.21 Million	CN¥174.22 Million ≈ $25.49 Million	0.131x	+80.97%
2012-12-31	CN¥1.16 Billion ≈ $170.37 Million	CN¥84.02 Million ≈ $12.30 Million	0.072x	+1.24%
2011-12-31	CN¥1.06 Billion ≈ $155.44 Million	CN¥75.72 Million ≈ $11.08 Million	0.071x	-70.36%
2010-12-31	CN¥176.62 Million ≈ $25.85 Million	CN¥42.47 Million ≈ $6.21 Million	0.240x	+159.86%
2009-12-31	CN¥110.01 Million ≈ $16.10 Million	CN¥10.18 Million ≈ $1.49 Million	0.093x	+2663.24%
2008-12-31	CN¥63.01 Million ≈ $9.22 Million	CN¥211.00K ≈ $30.88K	0.003x	--

About Hunan Er Kang Pharmaceutical

SHE:300267 China Drug Manufacturers - Specialty & Generic

Market Cap

$923.58 Million

CN¥6.31 Billion CNY

Market Cap Rank

#9139 Global

#2230 in China

Share Price

CN¥3.06

Change (1 day)

+1.66%

52-Week Range

CN¥2.88 - CN¥4.84

All Time High

CN¥17.60